filmov
tv
Non-Hodgkin Lymphoma: First Symptoms, Diagnosis & the LATEST Treatments | The Patient Story

Показать описание
After devoting years of her life to caring for cancer patients, Dr. Robyn Stacy-Humphries went from doctor to patient in an instant when she was diagnosed with diffuse large B-cell lymphoma, the most common form of non-Hodgkin lymphoma. Since her diagnosis she's relapsed twice and underwent a clinical trial for CAR T-cell therapy, that saved her life.
In this discussion, 3X DLBCL survivor Robyn and Dr. Josh Brody, a top lymphoma specialist with Mount Sinai, break down common first symptoms of DLBCL, standard of care and spotlight new and exciting immunotherapies revolutionizing lymphoma care including, CAR T-cell therapy and bispecific antibodies.
Thank you to Genmab and AbbVie for their support of our patient education program!
Join Our Community:
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
Contents of this video:
01:57 - Diffuse Large B-cell Lymphoma (DLBCL) First Symptoms
05:44 - Standard of Care: First Line Treatment
08:17 - Polatuzumab + RCHP
10:34 - The risk of Relapsing in DLBCL
18:27 - Car T-Cell Therapy
27:15 - Bispecific Antibodies
35:01 - Final Mesage to Patients
#cancersurvivor #cancerstories #cancer #thepatientstory #dlbcl #lymsm #nonhodgkinlymphoma #lymphoma #lymphomasurvivor #lymphomaawareness #cancertreatments #cancerresearch
In this discussion, 3X DLBCL survivor Robyn and Dr. Josh Brody, a top lymphoma specialist with Mount Sinai, break down common first symptoms of DLBCL, standard of care and spotlight new and exciting immunotherapies revolutionizing lymphoma care including, CAR T-cell therapy and bispecific antibodies.
Thank you to Genmab and AbbVie for their support of our patient education program!
Join Our Community:
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
Contents of this video:
01:57 - Diffuse Large B-cell Lymphoma (DLBCL) First Symptoms
05:44 - Standard of Care: First Line Treatment
08:17 - Polatuzumab + RCHP
10:34 - The risk of Relapsing in DLBCL
18:27 - Car T-Cell Therapy
27:15 - Bispecific Antibodies
35:01 - Final Mesage to Patients
#cancersurvivor #cancerstories #cancer #thepatientstory #dlbcl #lymsm #nonhodgkinlymphoma #lymphoma #lymphomasurvivor #lymphomaawareness #cancertreatments #cancerresearch
Комментарии